Tagged with EY

Haver Ecza Deposu Turkey We are here with a very young company, created in 2009, so only three years old. As you mentioned before the interview, you first started to work in the medical devices sector for one year and then you shifted toward a new business model. Could you tell us what was…

IMS Health Turkey Before we start with the interview I noticed that previously you were in charge of other regions aside from turkey. Is that still the case? If not why did IMS decide to separate Turkey from these regions ? Every third or fourth year, according to the growth of each country…

Biofarma Turkey Mr Sözeri, Pharmaceutical Executive’s readers are keen to discover, through our reports, prominent industry personalities, and they like to hear their stories. You have an outstanding career, having worked for both international and local giants – Deva, Abdi Ibrahim, Actavis, Astra Zeneca…- Can you tell us a little bit more…

Commercial Eyes What are some of the challenges facing pharmaceutical companies in Australia today? There are four major challenges within the Australian pharmaceutical industry at the moment. The increasing complexity of getting a medicine registered; getting a product reimbursed via the Pharmaceutical Benefits Scheme (PBS); dealing with the challenges of PBS reforms;…